Axsome Therapeutics (AXSM) PT Lowered to $221 at RBC Capital
RBC Capital analyst Leonid Timashev ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)